Latest News & Features
Americas
The US Food and Drug Administration has said that an Amgen biosimilar is indeed “highly similar” to AbbVie’s drug Humira in a document released for the advisory committee panel meeting due to be held tomorrow. 11 July 2016
Asia
Healthcare provider Zydus Cadila has signed a sub-licensing agreement with the Medicines Patent Pool (MPP) centring on the generic production of Daklinza (daclatasvir). 8 July 2016
Big Pharma
The Court of Justice of the European Union has said the beneficiary of a patent licence must pay the agreed royalty rate even if it does not infringe the patented technology. 7 July 2016
Americas
Law firm Jones Day has hired John Wehrli as a partner in the firm’s intellectual property practice in San Diego. 7 July 2016
Americas
Run Them Sweet, a US medical diagnostic company, has filed a class-action lawsuit alleging it was overcharged for foreign patent renewal fees by IP management company CPA Global. 6 July 2016
Americas
Pharmaceutical company Bristol-Myers Squibb has acquired Cormorant Pharmaceuticals in a deal valued at up to $95 million. 6 July 2016
Americas
The US Court of Appeals for the Federal Circuit ruled yesterday in the Amgen v Apotex case that bisoimilars companies must always notify brand name rivals 180 days before launching their products. 6 July 2016
Big Pharma
The European Medicines Agency announced yesterday that it has concluded its second inquiry in its case against pharmaceutical company Roche centring on the company’s pharmacovigilance duties. 5 July 2016
Asia
Pfizer has revealed that it will invest approximately $350 million to develop a Global Biotechnology Center in China. 5 July 2016
Americas
Pharmaceutical company Teva and US-based Antares Pharma have launched a generic version of Imitrex, which is used to treat migraines. 4 July 2016